Skip to main content

Hematopoietic Cell Transplantation as Treatment for Blood Cancers: The Team Approach

For Nurses and Advanced Practice Providers
Recorded on June 5, 2020

Click Here to Participate 

Format: Recorded Webinar
CE Credits Available Until: October 31, 2021

 

Target Audience

Advanced practice providers, nurses, and pharmacists involved in the care of patients with hematopoietic stem cell transplantation (HCT).

Description

This webinar will provide a basic overview of types of hematopoietic cell transplantation used in the treatment of blood cancers, including autologous, allogeneic, and reduced-intensity allogeneic stem-cell transplantation as a treatment option for blood cancers and describe strategies to manage treatment side effects as well as potential long-term and late effects of hematopoietic cell transplantation. Resources for patients, caregivers and healthcare providers will be discussed.
 

Learning Objectives

At the conclusion of this program, participants will be able to:

  • Describe the types of hematopoietic cell transplantation used in the treatment of blood cancers, including autologous, allogeneic, and reduced-intensity allogeneic stem-cell transplantation
  • Identify the methods of stem-cell collection used in patients with blood cancers
  • Explain the overarching goals of hematopoietic cell transplantation for all types of blood cancers
  • Explain hematopoietic cell transplantation as a treatment option for blood cancers
  • Describe strategies to manage treatment side effects as well as potential long-term and late effects of hematopoietic cell transplantation
  • Describe the roles of the pharmacist, the nurse and nurse practitioner in treating patients with HCT

 

Faculty

Ran Reshef, MD, MSc
Assistant Professor of Medicine
Columbia University Irving Medical Center 
Director, Translational Research
Blood and Marrow Transplantation and Cell Therapy Program
Division of Hematology/Oncology
Columbia Center for Transnational Immunology
Columbia University Medical Center
New York, NY

Rachel Abramova, PharmD
Clinical Pharmacy Manager 
Stem Cell Transplant/Myeloma
NewYork-Presbyterian Hospital 
Columbia University Irving Medical Center
New York, NY

Corinne Shamehdi, MPAS, PA-C
Physician Assistant
Blood and Marrow Transplant 
NewYork-Presbyterian Hospital 
Columbia University Irving Medical Center 
New York, NY

Krista McCarthy, LCSW
Senior Social Worker
Outpatient Hematology Oncology & BMT Program
NewYork-Presbyterian Hospital 
Columbia University Irving Medical Center 
New York, NY

Alison Hoffman, LMSW
Social Worker
Inpatient Hematology Oncology & BMT Program
NewYork-Presbyterian Hospital 
Columbia University Irving Medical Center 
New York, NY


Continuing Education

Registered Nursing Designation 
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.75 continuing education contact hours through the California Board of Registered Nursing.

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points. Please click here for test blueprint and points information.

ONCC review is only for designating content to be used for ILNA points and is not for NCPD accreditation. NCPD programs must be formally approved for contact hours by an acceptable accreditor/approver of nursing NCPD to be used for recertification by ONCC. If the NCPD provider fails to obtain formal approval to award contact hours by an acceptable accrediting/approval body, no information related to ONCC recertification or ILNA categories may be used in relation to the program.

Pharmacy Designation 
The Medical Learning Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The Medical Learning Institute, Inc. (MLI) designates this continuing education activity for 1.75 contact hour(s) (0.175 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: 0468-9999-20-020-H01-P

Type of Activity: Knowledge 

 

Participants must attend the free webinar in its entirety and submit the online evaluation form to earn credit. Once submitted, the certificate will be automatically generated as a PDF online.

 

Providers

This program is provided by The Leukemia & Lymphoma Society.

 

Click Here to Participate

Participants gain access to the webinar via the registration button above. To view system requirements for this program, please click here.

For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at profeducation@LLS.org.

 



< Back to Continuing Education